General MedicationsTOPICALGeneric
TRETINOIN
TRETINOIN
Standard Dose
0.075%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TRETINOIN is listed in Drugs@FDA under application 202209 (ANDA).
Marketing status: Discontinued Active ingredient TRETINOIN Form and strength CREAM;TOPICAL - 0.075% Sponsor ALLERGAN Submission history Latest submission status date: 2012-10-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview TRETINOIN is listed in Drugs@FDA under application 202209 (ANDA). Marketing status: Discontinued Active ingredient TRETINOIN Form and strength CREAM;TOPICAL - 0.075% Sponsor ALLERGAN Submission history Latest submission status date: 2012-10-11 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.